Enliven Therapeutics (ELVN) Earnings (2019 - 2026)
Enliven Therapeutics (ELVN) earnings from Mar 31, 2019 to Mar 31, 2026. The TTM Enliven Therapeutics (ELVN) earnings is -$99M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Enliven Therapeutics (ELVN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +4.17% |
| 3 Years TTM | +31.23% |
| 5 Years TTM | +17.34% |
| All Time TTM | +24.54% |
Annual Earnings change of Enliven Therapeutics (ELVN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$24M | -77.21% |
| 2025 | -$104M | +16.48% |
| 2024 | -$89M | +24.36% |
| 2023 | -$72M | +90.07% |
| 2022 | -$38M | -26.70% |
| 2021 | -$51M | +24.23% |
| 2020 | -$41M | +76.30% |
| 2019 | -$23M | N/A |
Comparison Enliven Therapeutics (ELVN) five years earnings CAGR with competitors
Enliven Therapeutics (ELVN) five years earnings CAGR is 17.34%.